PubChem,Structure,Name,IC50 (mM: Micro Molar),Reference,Inhibitor Target,Zinc ID
3194,,Ebselen,0.67 +/-  0.09 mM,https://doi.org/10.1038/s41586-020-2223-y,M(pro) Protease,
3117,,Disulfiram,9.35 pm 0.18 mM,https://doi.org/10.1038/s41586-020-2223-y,M(pro) Protease,
11313622,,Tideglusib,1.55 pm 0.30 mM,https://doi.org/10.1038/s41586-020-2223-y,M(pro) Protease,
2577,,Carmofur,1.82 pm 0.06 mM,https://doi.org/10.1038/s41586-020-2223-y,M(pro) Protease,
479503,,Shikonin,15.75 pm 8.22 mM,https://doi.org/10.1038/s41586-020-2223-y,M(pro) Protease,
219104,,PX-12,21.39 pm 7.06 mM,https://doi.org/10.1038/s41586-020-2223-y,M(pro) Protease,
57697,,Pemirolast,,Repurposing_Therapeutics_for_COVID-19-M-Smith-JC-Smith,S-ACE2,ZINC000005783214
2327,,Benserazide,,Repurposing_Therapeutics_for_COVID-19-M-Smith-JC-Smith,S-ACE2,ZINC000003830273
5280445,,Luteolin-monoarbinoside,,Repurposing_Therapeutics_for_COVID-19-M-Smith-JC-Smith,S-ACE2,ZINC000018185774
5369881,,Isoniazid Pyruvate,,Repurposing_Therapeutics_for_COVID-19-M-Smith-JC-Smith,ACE2,ZINC000004974291
5280343,,Quercetol;quercetin,,Repurposing_Therapeutics_for_COVID-19-M-Smith-JC-Smith,S-ACE2,ZINC000003869685
638678,,Protirelin,,Repurposing_Therapeutics_for_COVID-19-M-Smith-JC-Smith,S-ACE2,ZINC000004096261
2557,,Carbazochrome,,Repurposing_Therapeutics_for_COVID-19-M-Smith-JC-Smith,S-ACE2,ZINC000100029428
6604200,,Nitrofurantoin,,Repurposing_Therapeutics_for_COVID-19-M-Smith-JC-Smith,ACE2,ZINC000003875368
2327,,Benserazide,,Repurposing_Therapeutics_for_COVID-19-M-Smith-JC-Smith,S-ACE2,ZINC000003830273
135398654,,Sapropterin,,Repurposing_Therapeutics_for_COVID-19-M-Smith-JC-Smith,S-ACE2,ZINC000013585233
439693,,Vidarbine,,Repurposing_Therapeutics_for_COVID-19-M-Smith-JC-Smith,S-ACE2,ZINC000000970363
440735,,Eriodictyol,,Repurposing_Therapeutics_for_COVID-19-M-Smith-JC-Smith,ACE2,ZINC000000058117
23663400,,Tazobactum,,Repurposing_Therapeutics_for_COVID-19-M-Smith-JC-Smith,S-ACE2,ZINC000003787060
13266,,Phenformin-hcl,,Repurposing_Therapeutics_for_COVID-19-M-Smith-JC-Smith,S-ACE2,ZINC000005851063
114840,,Higenamine or Demethyl-coclaurine,,Repurposing_Therapeutics_for_COVID-19-M-Smith-JC-Smith,S-ACE2,ZINC000000896041
6918537,,Vildagliptin,,Repurposing_Therapeutics_for_COVID-19-M-Smith-JC-Smith,S-ACE2,ZINC000100003507
10531,,Ergoloid,,Repurposing_Therapeutics_for_COVID-19-M-Smith-JC-Smith,Spike,
3663,,Hypericin,,Repurposing_Therapeutics_for_COVID-19-M-Smith-JC-Smith,Spike,
10206,,Cepharanthine,,Repurposing_Therapeutics_for_COVID-19-M-Smith-JC-Smith,Spike,
45375808,, Sofosbuvir,,https://pubmed.ncbi.nlm.nih.gov/32119961/,RdRP (polymerase),
37542,,Ribavirin,,https://pubmed.ncbi.nlm.nih.gov/32119961/,RdRP (polymerase),
135565589,,IDX-184,,https://pubmed.ncbi.nlm.nih.gov/32119961/,RdRP (polymerase),
121304016,,Remdisivir,,https://pubmed.ncbi.nlm.nih.gov/32119961/,RdRP (polymerase),
135403798,,Theaflavin,,https://pubmed.ncbi.nlm.nih.gov/32167173,RdRP (polymerase),
64143,,Nelfinavir,,https://www.biorxiv.org/content/10.1101/2020.04.14.039925v1.full,M(pro) Protease,
10206,,Cepharanthine,,https://www.biorxiv.org/content/10.1101/2020.04.14.039925v1.full,Spike-Protein ; Inhibit viral attachment and entry,
3108,,Dipyridamole ,,https://doi.org/10.1101/2020.03.23.004580 ,M(pro) Protease,
441207,,Digitoxin ,,https://doi.org/10.1101/2020.04.09.034983 ,inhibits influenza cytokine storm,
2577,,Carmofur,,https://doi.org/10.1101/2020.04.09.033233 ,M(pro) Protease,
387447,,bortezomib,,https://doi.org/10.1101/2020.04.07.030734 ,virus infection-induced cytopathic effect ; TOXICITY concerns,
11977753,,dactolisib,,https://doi.org/10.1101/2020.04.07.030734 ,virus infection-induced cytopathic effect ; TOXICITY concerns,
5287969,,alvocidib  ,,https://doi.org/10.1101/2020.04.07.030734 ,virus infection-induced cytopathic effect ; TOXICITY concerns,
126941,,methotrexate ,,https://doi.org/10.1101/2020.04.07.030734 ,virus infection-induced cytopathic effect ; TOXICITY concerns,
11960529,,Veliparib,,https://doi.org/10.1101/2020.03.11.986836,N-terminal domain of nucleocapsid protein (N-NTD),
4858,,PJ-34,,https://doi.org/10.1101/2020.03.11.986836,N-terminal domain of nucleocapsid protein (N-NTD),
23725625,,olaparib,,https://doi.org/10.1101/2020.03.11.986836,N-terminal domain of nucleocapsid protein (N-NTD),
71488522,,mefuparib hydrochloride (CVL218),,https://doi.org/10.1101/2020.03.11.986836,N-terminal domain of nucleocapsid protein (N-NTD),
23725128,,Sofosbuvir (active form psi-7409),,https://doi.org/10.1101/2020.03.18.997585,RdRP (polymerase),
33039,,Alovudine (Keep the SMILES),,https://doi.org/10.1101/2020.03.18.997585,RdRP (polymerase),
72187,,Combivir (AZT triphosphate),,https://doi.org/10.1101/2020.03.18.997585,RdRP (polymerase),
5481180,,Tenofovir alafenamide (TAF triphosphate),,https://doi.org/10.1101/2020.03.18.997585; ,RdRP (polymerase),
135403798,,Theaflavin,,https://doi.org/10.1101/2020.03.26.009803,Spike Protein S1,
197020,,N4-hydroxycytidine (NHC),,https://doi.org/10.1101/2020.03.30.016485,Proposed as COVID-19 target,
9574768,,Tenofovir alafenamide (TAF) ,,https://doi.org/10.1101/2020.04.03.022939,RdRP (polymerase),
60877,,Emtricitabine,,https://doi.org/10.1101/2020.04.03.022939,RdRP (polymerase),
447043,,Azithromycine ,EC50 2.12,https://doi.org/10.1101/2020.04.03.023846,Viral replication,
9417,,Opipramol ,EC50 17.06,https://doi.org/10.1101/2020.04.03.023846,Viral replication,
441074,,Quinidine,EC50 5.11,https://doi.org/10.1101/2020.04.03.023846,Viral replication,
4594,,Omeprazol ,EC50 17.06,https://doi.org/10.1101/2020.04.03.023846,Viral replication,
392622,,ritonavir,,https://doi.org/10.1101/2020.01.31.929695,M(pro) Protease or 3CL-Pro,
92727,,lopinavir,,https://doi.org/10.1101/2020.01.31.929695,M(pro) Protease or 3CL-Pro,
213039,,darunavir,,https://doi.org/10.1101/2020.01.31.929695,Papain-like viral protease ,
4477,,niclosamide,0.28 mM,https://doi.org/10.1101/2020.03.20.999730,Anti viral efficacy,
6918155,,ciclesonide,4.33 mM,https://doi.org/10.1101/2020.03.20.999730,Anti viral efficacy,
2719,,Chloroquine ,12.0 mM,https://doi.org/10.1101/2020.03.20.999730,Anti viral efficacy,
92727,,lopinavir ,15.27 mM,https://doi.org/10.1101/2020.03.20.999730,Anti viral efficacy,
121304016,,remdesivir,8.24 mM,https://doi.org/10.1101/2020.03.20.999730,Anti viral efficacy,
5475,,Tilorone,4.09 mM,https://doi.org/10.1101/2020.03.20.999730,Anti viral efficacy,
5284373,,Cyclosporine,5.82 mM,https://doi.org/10.1101/2020.03.20.999730,Anti viral efficacy,
3955,,Loperamide,9.27 mM,https://doi.org/10.1101/2020.03.20.999730,Anti viral efficacy,
40692,,Mefloquine,4.33 mM,https://doi.org/10.1101/2020.03.20.999730,Anti viral efficacy,
2165,,Amodiaquine,5.15 mM,https://doi.org/10.1101/2020.03.20.999730,Anti viral efficacy,
5284613,,Proscillaridin,2.04 mM,https://doi.org/10.1101/2020.03.20.999730,Anti viral efficacy,
441207,,Digitoxin,0.23 mM,https://doi.org/10.1101/2020.03.20.999730,Anti viral efficacy,
2724385,,Digoxin,0.19 mM,https://doi.org/10.1101/2020.03.20.999730,Anti viral efficacy,
3598,,Hexachlorophene,0.90 mM,https://doi.org/10.1101/2020.03.20.999730,Anti viral efficacy,
169870,,Hydroxyprogesterone caproate,6.30 mM,https://doi.org/10.1101/2020.03.20.999730,Anti viral efficacy,
3085092,,Salinomycin,0.24 mM,https://doi.org/10.1101/2020.03.20.999730,Anti viral efficacy,
439501,,Ouabain,< 0.097 mM,https://doi.org/10.1101/2020.03.20.999730,Anti viral efficacy,
10206,,Cepharanthine,4.47  mM,https://doi.org/10.1101/2020.03.20.999730,Anti viral efficacy,
6918155,,Ciclesonide,4.33 mM,https://doi.org/10.1101/2020.03.20.999730,Anti viral efficacy,
16779,,Oxyclozanide,3.71 mM,https://doi.org/10.1101/2020.03.20.999730,Anti viral efficacy,
166548,,Anidulafungin,4.64 mM,https://doi.org/10.1101/2020.03.20.999730,Anti viral efficacy,
49803313,,Gilteritinib,6.76 mM,https://doi.org/10.1101/2020.03.20.999730,Anti viral efficacy,
275182,,Berbamine,7.87 mM,https://doi.org/10.1101/2020.03.20.999730,Anti viral efficacy,
73078,,Tetrandrine,3.00 mM,https://doi.org/10.1101/2020.03.20.999730,Anti viral efficacy,
46220502,,Abemaciclib,6.62 mM,https://doi.org/10.1101/2020.03.20.999730,Anti viral efficacy,
16220172,,Ivacaftor,6.57 mM,https://doi.org/10.1101/2020.03.20.999730,Anti viral efficacy,
154257,,Bazedoxifene,3.44 mM,https://doi.org/10.1101/2020.03.20.999730,Anti viral efficacy,
4477,,niclosamide,0.28 mM,https://doi.org/10.1101/2020.03.20.999730,Anti viral efficacy,
135449332,,Eltrombopag,8.27 mM,https://doi.org/10.1101/2020.03.20.999730,Anti viral efficacy,
148192,,Atazanavir,,https://doi.org/10.1101/2020.04.04.020925,M(pro) Protease,
11729855,,Scopadulcic acid B,,https://doi.org/10.1101/2020.03.31.017657,Spike Protein,
64982,,Baicalin,,https://doi.org/10.1101/2020.03.31.017657,Spike Protein,
1548994,,Sylibinin,,https://doi.org/10.1101/2020.03.31.017657,Spike Protein,
65727,,Solanidine,,https://doi.org/10.1101/2020.03.31.017657,Spike Protein,
932,,Naringenin,,https://doi.org/10.1101/2020.03.31.017657,Spike Protein,
9548717,,Oleanane,,https://doi.org/10.1101/2020.03.31.017657,Spike Protein,
57347487,,Dammarenolic acid,,https://doi.org/10.1101/2020.03.31.017657,M(pro) Protease,
5280343,,Quercetin,,https://doi.org/10.1101/2020.03.31.017657,M(pro) Protease,
65727,,Solanidine,,https://doi.org/10.1101/2020.03.31.017657,M(pro) Protease,
1548994,,Silybinin,,https://doi.org/10.1101/2020.03.31.017657,M(pro) Protease,
100332,,Loliolide,,https://doi.org/10.1101/2020.03.31.017657,M(pro) Protease,
479503,,Shikonin,,https://doi.org/10.1101/2020.03.31.017657,M(pro) Protease,
64982,,baicalin ,kd 11.50 +/- 0.37; IC50 6.41 +/- 0.95,https://doi.org/10.1101/2020.04.13.038687,M(pro) Protease or 3CL-Pro,
5281605,,baicalein,kd 4.03 +/- 0.37; 0.94 +/- 0.2,https://doi.org/10.1101/2020.04.13.038687,M(pro) Protease or 3CL-Pro,
54685921,,Hispidin,,https://arxiv.org/abs/2004.08920,M(pro) Protease or 3CL-Pro,
100927767,,Lepidine E,,https://arxiv.org/abs/2004.08920,M(pro) Protease or 3CL-Pro,
135398658,,Folic acid,,https://arxiv.org/abs/2004.08920,M(pro) Protease or 3CL-Pro,
237,,Mepacrine,,https://arxiv.org/ftp/arxiv/papers/2003/2003.10642.pdf,M(pro) Protease,
3652,,Chloroquine,,https://arxiv.org/ftp/arxiv/papers/2003/2003.10642.pdf,M(pro) Protease,
3652,,Hydroxychloroquine,,https://arxiv.org/ftp/arxiv/papers/2003/2003.10642.pdf,M(pro) Protease,
12314177,,Phomarin,,https://arxiv.org/ftp/arxiv/papers/2003/2003.10642.pdf,M(pro) Protease,
11594161,,Jensenone,,https://arxiv.org/ftp/arxiv/papers/2004/2004.00217.pdf,M(pro) Protease,
135398743,,Rifabutin,,https://arxiv.org/ftp/arxiv/papers/2004/2004.07086.pdf,RdRP (polymerase),
135403821,,Rifapentine,,https://arxiv.org/ftp/arxiv/papers/2004/2004.07086.pdf,RdRP (polymerase),
10034073,,Fidaxomicin,,https://arxiv.org/ftp/arxiv/papers/2004/2004.07086.pdf,RdRP (polymerase),
135442196,,7-methyl-guanosine-5'-triphosphate-5'-guanosine ,,https://arxiv.org/ftp/arxiv/papers/2004/2004.07086.pdf,RdRP (polymerase),
6321424,,Ivermectin,,https://arxiv.org/ftp/arxiv/papers/2004/2004.07086.pdf,RdRP (polymerase),
40943462,,ZINC09128258,,https://arxiv.org/ftp/arxiv/papers/2004/2004.07086.pdf,RdRP (polymerase),
41259301,,ZINC 09883305,,https://arxiv.org/ftp/arxiv/papers/2004/2004.07086.pdf,RdRP (polymerase),
64971,,Betulinic acid,,https://pubmed.ncbi.nlm.nih.gov/32113846/,Replication and 3CL-Pro,
5372945,,Coumaroyltyramine,,https://pubmed.ncbi.nlm.nih.gov/32113846/,PLpro ,
5372945,,Coumaroyltyramine,,https://pubmed.ncbi.nlm.nih.gov/32113846/,3CL-Pro,
160254,,Cryptotanshinone,,https://pubmed.ncbi.nlm.nih.gov/32113846/,PLpro,
160254,,Cryptotanshinone,,https://pubmed.ncbi.nlm.nih.gov/32113846/,3CL-Pro,
8550,,Desmethoxyreserpine,,https://pubmed.ncbi.nlm.nih.gov/32113846/,3CL-Pro,
5280581,,Dihomo-?-linolenic acid,,https://pubmed.ncbi.nlm.nih.gov/32113846/,3CL-Pro,
11425923,,Dihydrotanshinone ?,,https://pubmed.ncbi.nlm.nih.gov/32113846/,Spike Protein,
5280863,,Kaempferol,,https://pubmed.ncbi.nlm.nih.gov/32113846/,PLpro ,
5280863,,Kaempferol,,https://pubmed.ncbi.nlm.nih.gov/32113846/,3CL-Pro,
261166,,Lignan,,https://pubmed.ncbi.nlm.nih.gov/32113846/,3CL-Pro,
5280537,,Moupinamide,,https://pubmed.ncbi.nlm.nih.gov/32113846/,PL-Pro,
6440659,,N-cis-feruloyltyramine,,https://pubmed.ncbi.nlm.nih.gov/32113846/,PLpro ,
6440659,,N-cis-feruloyltyramine,,https://pubmed.ncbi.nlm.nih.gov/32113846/,3CL-Pro,
5280343,,Quercetin,,https://pubmed.ncbi.nlm.nih.gov/32113846/,PLpro ,
5280343,,Quercetin,,https://pubmed.ncbi.nlm.nih.gov/32113846/,3CL-Pro,
94162,,Sugiol,,https://pubmed.ncbi.nlm.nih.gov/32113846/,3CL-Pro,
164676,,Tanshinone IIa,,https://pubmed.ncbi.nlm.nih.gov/32113846/,PLpro (Papain-like Protease),
164676,,Tanshinone IIa,,https://pubmed.ncbi.nlm.nih.gov/32113846/,3CL-Pro,
145996610,,EIDD-2801 ,,https://pubs.acs.org/doi/10.1021/cen-09812-buscon5,RNA replication RdRp,
25126798,,Ruxolitinib,,https://pubs.acs.org/doi/10.1021/cen-09814-buscon3,Blocks enzymes in JAK-STAT pathway,
492405,,Favipiravir,,https://pubs.acs.org/doi/10.1021/cen-09815-buscon4,RdRP (polymerase),
44205240,,baricitinib,,https://pubs.acs.org/doi/10.1021/cen-09815-buscon17,Cytokine storm,
25126798,,Ruxolitinib,,https://pubs.acs.org/doi/10.1021/cen-09815-buscon17,Cytokine storm,
92722,,Argatroban,,http://doi.org/10.26434/chemrxiv.12009582.v1,hTMPRSS2,
5496659,,Otamixaban,,http://doi.org/10.26434/chemrxiv.12009582.v1,hTMPRSS2,
4689977,,4689977,,http://doi.org/10.26434/chemrxiv.12009582.v1,hTMPRSS2,
10280735,,Edoxaban,,http://doi.org/10.26434/chemrxiv.12009582.v1,hTMPRSS2,
4413,,Nafamostat,,http://doi.org/10.26434/chemrxiv.12009582.v1,hTMPRSS2,
56663319,,56663319,,http://doi.org/10.26434/chemrxiv.12009582.v1,hTMPRSS2,
11641515,,Letaxaban,,http://doi.org/10.26434/chemrxiv.12009582.v1,hTMPRSS2,
9912771,,Darexaban,,http://doi.org/10.26434/chemrxiv.12009582.v1,hTMPRSS2,
213039,,Darunavir,,https://pubmed.ncbi.nlm.nih.gov/32210741/,M(pro) Protease,
4369144,,IH2,,https://pubmed.ncbi.nlm.nih.gov/32210741/,M(pro) Protease,
444214,,MDL,,https://pubmed.ncbi.nlm.nih.gov/32210741/,M(pro) Protease,
444603,,bms-189090,,https://pubmed.ncbi.nlm.nih.gov/32210741/,M(pro) Protease,
444743,,IH1,,https://pubmed.ncbi.nlm.nih.gov/32210741/,M(pro) Protease,
444745,,IH3,,https://pubmed.ncbi.nlm.nih.gov/32210741/,M(pro) Protease,
444756,,3IN,,https://pubmed.ncbi.nlm.nih.gov/32210741/,M(pro) Protease,
457409,,GRL-98065,,https://pubmed.ncbi.nlm.nih.gov/32210741/,M(pro) Protease,
2726,,Chloropromazine (CPZ),~10microMolar,https://www.biorxiv.org/content/10.1101/2020.05.05.079608v1,Sars COV2 activity,
5284360,,Camostat Mesylate,,https://www.biorxiv.org/content/10.1101/2020.05.04.077826v1.full.pdf,TMPRSS2 inhibitor,
5702220,,Bromhexine hydrochloride (BHH),,https://www.biorxiv.org/content/10.1101/2020.05.04.077826v1.full.pdf,TMPRSS2 inhibitor,
1701,, 4-(2-aminomethyl)benzenesulfonyl fluoride (AEBSF) ,,https://www.biorxiv.org/content/10.1101/2020.05.04.077826v1.full.pdf,TMPRSS2 inhibitor,
441243,,Saquinavir,,https://pubmed.ncbi.nlm.nih.gov/32210741/,M(pro) Protease,
92727,,Lopinavir,,https://pubmed.ncbi.nlm.nih.gov/32210741/,M(pro) Protease,
54682461,,Tipranavir,,https://pubmed.ncbi.nlm.nih.gov/32210741/,M(pro) Protease,
213039,,Darunavir,,https://pubmed.ncbi.nlm.nih.gov/32210741/,M(pro) Protease,
65016,,Amprenavir,,https://pubmed.ncbi.nlm.nih.gov/32210741/,M(pro) Protease,
148192,,Atazanavir,,https://pubmed.ncbi.nlm.nih.gov/32210741/,M(pro) Protease,
392622,,ritonavir,,https://pubmed.ncbi.nlm.nih.gov/32210741/,M(pro) Protease,
73386,,Petunidin,,https://arxiv.org/ftp/arxiv/papers/2005/2005.11767.pdf,M(pro) Protease,
5281605,,Baicalein,,https://arxiv.org/ftp/arxiv/papers/2005/2005.11767.pdf,M(pro) Protease,
128861,,Cyanidin,,https://arxiv.org/ftp/arxiv/papers/2005/2005.11767.pdf,PLpro,
466078,,"7-Hydroxy-3',4'-methylenedioxyflavan",,https://arxiv.org/ftp/arxiv/papers/2005/2005.11767.pdf,SGpRBD (Spike Glycoprotein Receptor binding domain),
5280343,,Quercetin,,https://arxiv.org/ftp/arxiv/papers/2005/2005.11767.pdf,RdRp,
5281855,,Ellagic acid,,https://arxiv.org/ftp/arxiv/papers/2005/2005.11767.pdf,ACE2,
16148290,,Azobechalcone,,https://arxiv.org/ftp/arxiv/papers/2005/2005.11254.pdf,RdRp1,
135398735,,Rifampin,,https://arxiv.org/ftp/arxiv/papers/2005/2005.11254.pdf,M(pro) Protease,
135398735,,Rifampin,,https://arxiv.org/ftp/arxiv/papers/2005/2005.11254.pdf,Spike Protein,
101630349,,Isolophirachalcone,,https://arxiv.org/ftp/arxiv/papers/2005/2005.11254.pdf,RdRp1,
73078,,Tetrandrine,,https://arxiv.org/ftp/arxiv/papers/2005/2005.11254.pdf,RdRp1,
73481,,Fangchinoline,,https://arxiv.org/ftp/arxiv/papers/2005/2005.11254.pdf,RdRp1,
3194,,Ebselen,,https://arxiv.org/ftp/arxiv/papers/2005/2005.09805.pdf,Mpro,
444810,,R-Chloroquine,1.975,https://www.biorxiv.org/content/10.1101/2020.05.26.114033v1.full.pdf,S form is  active against SARS-CoV-2 than R form,
639540,,S-Chloroquine,1.761,https://www.biorxiv.org/content/10.1101/2020.05.26.114033v1.full.pdf,S form is  active against SARS-CoV-2 than R form,
178395,,R-Hydroxychloroquine,2.445,https://www.biorxiv.org/content/10.1101/2020.05.26.114033v1.full.pdf,S form is  active against SARS-CoV-2 than R form,
178396,,S-Hydroxychloroquine,1.444,https://www.biorxiv.org/content/10.1101/2020.05.26.114033v1.full.pdf,S form is  active against SARS-CoV-2 than R form,
24873435,,Simeprevir,EC50=4.082mM; CC50 = 19.33 mM,https://www.biorxiv.org/content/10.1101/2020.05.26.116020v1.full.pdf,suppressor of SARS-CoV-2 replication (RdRP?),
121304016,,remdesivir,EC50=4.269mM; CC50 = > 200 mM,https://www.biorxiv.org/content/10.1101/2020.05.26.116020v1.full.pdf,suppressor of SARS-CoV-2 replication (RdRP?),
16362,,Pimozide,IC50=42.0+/- 2,https://www.biorxiv.org/content/10.1101/2020.05.23.112235v1.full.pdf,Mpro,
3191,,Ebastine,IC50=57.0+/- 12,https://www.biorxiv.org/content/10.1101/2020.05.23.112235v1.full.pdf,Mpro,
6440352,,Rupintrivir,IC50=68.0+/- 7,https://www.biorxiv.org/content/10.1101/2020.05.23.112235v1.full.pdf,Mpro,
65863,,Berpridil,IC50=72.0+/- 3,https://www.biorxiv.org/content/10.1101/2020.05.23.112235v1.full.pdf,Mpro,
65863,,Sertaconazole,IC50=85.0+/- 3,https://www.biorxiv.org/content/10.1101/2020.05.23.112235v1.full.pdf,Mpro,
104850,,Rimonabant,IC50=85.0+/- 3,https://www.biorxiv.org/content/10.1101/2020.05.23.112235v1.full.pdf,Mpro,
5353853,,Oxiconazole,IC50=99.0+/- 6,https://www.biorxiv.org/content/10.1101/2020.05.23.112235v1.full.pdf,Mpro,
3793,,Itraconazole,IC50=111.0+/- 35,https://www.biorxiv.org/content/10.1101/2020.05.23.112235v1.full.pdf,Mpro,
54682461,,Tipranavir,IC50=180.0+/- 20,https://www.biorxiv.org/content/10.1101/2020.05.23.112235v1.full.pdf,Mpro,
64143,,Nelfinavir,IC50=234.0+/- 15,https://www.biorxiv.org/content/10.1101/2020.05.23.112235v1.full.pdf,Mpro,
5735,,Zopiclone,IC50=349.0+/- 77,https://www.biorxiv.org/content/10.1101/2020.05.23.112235v1.full.pdf,Mpro,
5572,,Trihexyphenidyl,IC50=370.0+/- 53,https://www.biorxiv.org/content/10.1101/2020.05.23.112235v1.full.pdf,Mpro,
6918485,,Isavuconazole,IC50=438.0+/- 11,https://www.biorxiv.org/content/10.1101/2020.05.23.112235v1.full.pdf,Mpro,
92727,,Lopinavir,IC50=486.0+/- 2,https://www.biorxiv.org/content/10.1101/2020.05.23.112235v1.full.pdf,Mpro,
26987,,Clemastine,IC50=497.0+/- 148,https://www.biorxiv.org/content/10.1101/2020.05.23.112235v1.full.pdf,Mpro,
4167,,Metixene,IC50=635.0+/- 43,https://www.biorxiv.org/content/10.1101/2020.05.23.112235v1.full.pdf,Mpro,
60835,,Duloxetine,IC50=3047.0+/- 634,https://www.biorxiv.org/content/10.1101/2020.05.23.112235v1.full.pdf,Mpro,
51634,,Miglustat,EC50=41.0 +/- 22 mM,https://www.biorxiv.org/content/10.1101/2020.05.18.101691v1.full.pdf,Anti viral activity,
2577,,Carmofur,IC50=24.30 +/- 3.61 mM; CC50=133.37 +/- 12.23 mM,https://www.nature.com/articles/s41594-020-0440-6,Mpro,
76310291,,CHEMBL3109593,IC50: 0.4909 mM; CC50: 50 ,https://www.biorxiv.org/content/10.1101/2020.05.17.100404v1,Anti viral activity,
2719,,Chloroquine,IC50:1.03 mM; CC50: 50,https://www.biorxiv.org/content/10.1101/2020.05.17.100404v1,Anti viral activity,
45137165,,PBDNJ0803,IC50: 2.026 mM; CC50: 50,https://www.biorxiv.org/content/10.1101/2020.05.17.100404v1,Anti viral activity,
121304016,,remdesivir,IC50: 1.842 mM; CC50: 50,https://www.biorxiv.org/content/10.1101/2020.05.17.100404v1,Anti viral activity,
